Skip to content
Screener

Roivant Sciences ROIV Q2 2024 earnings

Reported November 12, 2024 · Before market open

Revenue$4.5MMiss by $41.4M
EPS-$0.29Miss by $0.04
Revenue estimate$45.9M
EPS estimate-$0.25

Next report

Nov 9, 2026 (in 2 months)
Revenue estimate$3.4M
EPS estimate-$0.41

Financials

Q2 2024

Income statement

See full
Revenue$4.5M+22.7%
Operating income-$341.7M-59.8%
Net income-$230.2M+24.4%
EPS (diluted)-$0.31+22.5%

Balance sheet

See full
Cash & equivalents$123.5M-91.3%
Total debt$52.7M-89.4%
Total equity$5.2B+443%
Total assets$6.2B+200%

Cash flow

See full
Operating cash flow-$266.8M-35.8%
CapEx$996.0K+262%
Free cash flow-$267.8M-36.1%

Valuation & ratios

Valuation

as of 09/30/24
See full
Market cap$8.49B-5.6%
Enterprise value$8.42B+4.3%
P/E1.7×—
P/S229.2×+16.6×

Profitability

See full
Operating margin12,642.1%+11,093pp
Net margin13,391.9%+11,669pp
FCF margin-2,108.7%+109pp

Returns & leverage

See full
Return on equity162.6%+119pp
Debt / equity0×-0.5×
Current ratio10.4×+4.6×

Segments

By segment

See full
Reportable Segment$4.5M-45.3%

FAQ

When did Roivant Sciences report Q2 2024 earnings?
Roivant Sciences (ROIV) reported Q2 2024 earnings on November 12, 2024 before market open.
What were Roivant Sciences's Q2 2024 revenue and EPS?
Roivant Sciences reported revenue of $4.5M and eps of $-0.29 for Q2 2024.
Did Roivant Sciences beat estimates in Q2 2024?
Revenue missed the consensus estimate of $45.9M by $41.4M. EPS missed the consensus estimate of $-0.25 by $0.04.
Where can I find Roivant Sciences's Q2 2024 SEC filings?
You can read the 8-K earnings release (0001140361-24-046015) and the 10-Q periodic report (0001140361-24-046019) directly on SEC EDGAR. The filing index links above go to sec.gov.